Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Vose

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2013
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 studyP L Zinzani, J M Vose, M S Czuczman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
The American Journal of Medicine|December 1, 1991
Autologous bone marrow transplantation for patients with relapsed Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomasJ M Vose, R L Wahl, M Saleh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family membersF J Rutar, S C Augustine, D Colcher, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
JAMA|October 25, 1995
Multiple organ dysfunction syndrome in bone marrow transplantationW D Haire, E I Ruby, B G Gordon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphomaZ S Pavletic, P J Bierman, J M Vose, et al.
The American Review of Respiratory Disease|August 1, 1992
Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin diseaseJ H Sisson, A B Thompson, J R Anderson, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2013
Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 studyP L Zinzani, J M Vose, M S Czuczman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
The American Journal of Medicine|December 1, 1991
Autologous bone marrow transplantation for patients with relapsed Hodgkin's diseaseJ O Armitage, P J Bierman, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomasJ M Vose, R L Wahl, M Saleh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family membersF J Rutar, S C Augustine, D Colcher, et al.
Experimental Hematology|July 1, 1995
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignanciesA Kessinger, M R Bishop, J D Jackson, et al.
JAMA|October 25, 1995
Multiple organ dysfunction syndrome in bone marrow transplantationW D Haire, E I Ruby, B G Gordon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphomaZ S Pavletic, P J Bierman, J M Vose, et al.
The American Review of Respiratory Disease|August 1, 1992
Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin diseaseJ H Sisson, A B Thompson, J R Anderson, et al.
Pageof 14